ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Sep 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
Fusion Science and Technology
October 2025
Latest News
A wave of new U.S.-U.K. deals ahead of Trump’s state visit
President Trump will arrive in the United Kingdom this week for a state visit that promises to include the usual pomp and ceremony alongside the signing of a landmark new agreement on U.S.-U.K. nuclear collaboration.
Truong V. Vo, Brian W. Smith, Frederic A. Simonen, Steven R. Doctor
Nuclear Technology | Volume 92 | Number 3 | December 1990 | Pages 291-299
Technical Paper | Fission Reactor | doi.org/10.13182/NT90-A16231
Articles are hosted by Taylor and Francis Online.
To provide a technical basis for improved in-service inspection (ISI) plans, Pacific Northwest Laboratory (PNL) has developed and applied a method that uses results of probabilistic risk assessment to establish piping system ISI priorities. In the PNL program, the feasibility of generic ISI guidances is being conducted in two phases. Phase I identifies and prioritizes the systems most relevant to plant safety. These evaluations lead to the development of comprehensive ISI guidances for pressure boundary systems and components that take place in Phase II.